Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Carisma Therapeutics Inc CARM

Healthcare Biotechnology
Carisma Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on utilizing its proprietary macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. It is developing a pipeline of product candidates, with an initial focus on advancing multiple ex vivo autologous and in vivo CAR-M therapies for the... see more

Recent & Breaking News (NDAQ:CARM)

LAWSUIT FILED: SESEN BIO Sued for Securities Law Violations; Investors Should Contact Block & Leviton for More Information

Newsfile August 23, 2021

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Sesen Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Newsfile August 23, 2021

Sesen Shareholder Alert

Newsfile August 22, 2021

SESN DEADLINE: Investors With Substantial Losses Have Opportunity to Lead the Sesen Bio, Inc. Class Action Lawsuit

PR Newswire August 21, 2021

Sesen Deadline Alert

Newsfile August 21, 2021

SESEN BIO ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Sesen Bio, Inc. and Encourages Investors to Contact the Firm

Business Wire August 20, 2021

INVESTOR ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Sesen Bio, Inc. (SESN) Investors

Business Wire August 20, 2021

Berman Tabacco Alerts Investors with Losses in Excess of $50,000 of Deadline for Seeking Lead Plaintiff in Class Action Against Sesen Bio, Inc. (SESN)

Newsfile August 20, 2021

SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Sesen Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Business Wire August 20, 2021

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Sesen Bio, Inc. (SESN) Investors

Business Wire August 20, 2021

SESN CLASS ACTION NOTICE: The Law Offices of Frank R. Cruz Files Securities Fraud Lawsuit Against Sesen Bio, Inc.

Business Wire August 20, 2021

SESN CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit Against Sesen Bio, Inc.

Business Wire August 19, 2021

SESEN ALERT: Bragar Eagel & Squire, P.C. is Investigating Sesen Bio, Inc. on Behalf of Sesen Stockholders and Encourages Investors to Contact the Firm

Business Wire August 19, 2021

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Its Investigation of Sesen Bio, Inc. (SESN) on Behalf of Investors

Business Wire August 19, 2021

Lost Money in Sesen Bio, Inc.?

Business Wire August 19, 2021

INVESTOR ALERT: Law Offices of Howard G. Smith Continues Its Investigation of Sesen Bio, Inc. (SESN) on Behalf of Investors

Business Wire August 19, 2021

SESEN BIO INVESTIGATION: Block & Leviton Investigates Sesen Bio For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm

Newsfile August 19, 2021

EQUITY ALERT: Rosen Law Firm Encourages Sesen Bio, Inc. Investors with Losses to Inquire About Class Action Investigation - SESN

Business Wire August 19, 2021

Investigation Alert: Kessler Topaz Meltzer & Check, LLP is Investigating Securities Fraud Claims on Behalf of Sesen Bio, Inc. (NASDAQ: SESN) Investors

PR Newswire August 19, 2021

Lost Money in Sesen Bio, Inc.?

Business Wire August 18, 2021